CellDiffuser: Multimodal Optical Time-Stretch Imaging Flow Cytometry and Diffusion Models for Lung Cancer Immunotherapy Diagnosis
- 15 September 2026
- journal article
- Published by American Chemical Society (ACS) in ACS Photonics
- Vol. 13 (19) , 5787-5796
Abstract
Immune checkpoint inhibitors have emerged as frontline therapies for lung cancer, yet the lack of reliable biomarkers for predicting the treatment response remains a critical challenge. While single-cell analysis offers a potent approach to probing physiological states, conventional techniques suffer from limited throughput and insufficient multimodal profiling capability. To address the aforementioned issues, we propose a novel framework for lung cancer immunotherapy diagnosis. Specifically, we develop multimodal optical time-stretch imaging flow cytometry (OTS-IFC) that simultaneously acquires label-free bright-field (BF) and quantitative phase (QP) images at a throughput of 10,000 cells/s. In response to the influence of phase unwrapping artifacts, we propose CellDiffuser, an intermediate domain transformation diffusion model that aligns BF and QP images in a shared latent space at a preselected time step, thus generating high-fidelity synthesized QP images. CellDiffuser achieves an SSIM of 0.747 in the leukocyte immunotherapy response prediction data set and an SSIM of 0.708 in the A549 cell death state identification data set. Finally, our framework demonstrates its practical utility in lung cancer immunotherapy diagnosis in the above two clinically relevant data sets. This work establishes a cost-effective, high-throughput framework for single-cell phenotyping, offering a new paradigm to guide lung cancer personalized immunotherapy diagnosis. The code is available at: https://github.com/yzygit1230/CellDiffuser.Keywords
Funding Information
- Hubei University of Technology (2025025)
- Natural Science Foundation of Hubei Province (2025AFB055)
- Natural Science Foundation of Hubei Province (2026AFB554)
- Hubei Provincial Department of Education (Q20241403)
- Fundamental Research Funds for the Central Universities (2042026YXB026)
- Shenzhen Science and Technology Innovation Program (JCYJ20230807090207014)
- National Basic Research Program of China (973 Program) (2023YFF0723300)
- National Natural Science Foundation of China (NSFC) (62475198)
- National Natural Science Foundation of China (NSFC) (62505232)
This publication has 34 references indexed in Scilit:
- Frequency-guided wavelet network for label-free cell death pathway prediction in lung cancer chemotherapyDisplays, 2025
- Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung CancerJAMA Oncology, 2025
- Label-Free Prediction of Immunotherapy Response in Lung CancerACS Photonics, 2024
- Liquid Biopsy in Lung Cancer: Nano–Flow Cytometry Detection of Non–Small Cell Lung Cancer in BloodLaboratory Investigation, 2024
- Single-cell transcriptomes identify patient-tailored therapies for selective co-inhibition of cancer clonesNature Communications, 2024
- A Markov Chain approach for video-based virtual try-on with denoising diffusion generative adversarial networkKnowledge-Based Systems, 2024
- Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancerCancer Cell, 2024
- The global burden of lung cancer: current status and future trendsNature Reviews Clinical Oncology, 2023
- Integrated analysis of multimodal single-cell dataCell, 2021
- Serial time-encoded amplified imaging for real-time observation of fast dynamic phenomenaNature, 2009